Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN)

On January 30, Jefferies initiated sum of enGene Holdings Inc. (NASDAQ:ENGN) with a Buy standing and a $28 terms target, highlighting the company’s ongoing pivotal survey successful high-risk non-muscle invasive bladder crab (NMIBC), with a cardinal information update expected successful the 2nd fractional of 2026.

enGene Holdings Inc. (NASDAQ:ENGN) is positioning itself arsenic a differentiated subordinate successful the bladder crab attraction scenery arsenic it advances detalimogene voraplasmid, its pb non-viral cistron therapy candidate, into late-stage development. Beyond objective momentum, enGene has strengthened its fiscal footing. On January 21, the institution expanded its indebtedness installation with Hercules Capital to up to $125 million, securing further non-dilutive financing to enactment its planned Biologics License Application and imaginable U.S. commercialization. The amended statement provides $25 cardinal instantly to refinance existing indebtedness and up to $100 cardinal successful further tranches tied to clinical, regulatory, and commercialized milestones. This superior operation enhances flexibility arsenic enGene transitions from a development-stage biotech to a imaginable commercial-stage institution successful a competitory but high-need oncology market.

Founded successful 1999 and headquartered successful Saint-Laurent, Quebec, enGene Holdings Inc. (NASDAQ:ENGN) leverages its proprietary Dually Derivatized Chitosan (DDX) level to make non-viral familial medicines targeting mucosal diseases. With pivotal information connected the horizon, strengthened liquidity, and a differentiated therapeutic approach, enGene represents a high-risk, high-reward accidental for investors seeking vulnerability to innovative oncology platforms with meaningful upside potential.

While we admit the imaginable of ENGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 8 Up and Coming Streaming Companies and Services and 9 High Growth Canadian Stocks to Buy

Disclosure: None.